Skip to main content
+1 (855) PLE.XISION (753.9474)
info@plexision.com
Login
PERSONALIZED MEDICINE FOR BETTER HEALTH
Home
About Us
Who We Are
What We Do
Technology
Our Team
Transplantation
Pleximmune
TM
Transplant Rejection
For Patients
Rationale
Test Description
Who Can Benefit
Test Procedures
Interpreting Results
Insurance Coverage
Patient Support
For Healthcare Providers
Description
Benefits
Technology Overview
Intended Use
References
Resource
Ordering Information
Pleximark
TM
For patients and providers
Ordering Information
FAQ
PlexCMV
TM
For patients and providers
Ordering Information
PlexEBV
TM
For patients and providers
Ordering Information
Pipeline
Covid-19
Immuno-Oncology
Tumor Immunology
Tumor Immunotherapy
Unmet Needs
Personalized Immunotherapy
Services
Support
Addditonal Form(s)
Search
FAQ
Contact Us
Careers
Enter your keywords
Bootstrap
You are here
Home
/ Bootstrap
There is currently no content classified with this term.
Abstracts
Events
General Articles
Research
FDA approves Pleximmune
TM
for personalized prediction of transplant rejection in children
American Transplant Congress, Seattle | 18–22 May 2013
Prognostic cell-based assay predicts acute cellular rejection in pre- and post-transplant testing of children with liver and intestine transplantation (LTx, ITx).
Predicting cytomegalovirus viremia….with CMV-specific T-cells
Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children
Pleximmune test to predict liver transplant rejection presented at the Liver meeting in Washington DC - November 3, 2013.
Plexision's PK/PD solutions presented at CHI's Immunogenicity Summit in Washington, DC - November 11, 2013.
ESOT Congress, Vienna | Sept 8-11
Technology - How It Works
Combined Biomarker and Drug Development
acute cellular rejection
Adaptive
american transplant congress
Bootstrap
CellBased
Drug
Drupal
European Society for Organ Transplantation Congress
Individual
liver meeting 2013
Modern
organ transplantation
Personalized
Plexision
R&D
rejection risk test
Technology
Video
washington dc
